Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders

[1]  R. Baldassano,et al.  Infliximab Therapy in Children and Adolescents with Inflammatory Bowel Disease , 2012, Drugs.

[2]  G. Mazariegos,et al.  Chronic high Epstein–Barr viral load carriage in pediatric small bowel transplant recipients , 2009, Pediatric transplantation.

[3]  E. Jaffe.  ATYPICAL LYMPHOPROLIFERATIVE DISORDERS , 2010 .

[4]  K. Basso,et al.  Genetic and phenotypic analysis of B‐cell post‐transplant lymphoproliferative disorders provides insights into disease biology , 2008, Hematological oncology.

[5]  P. Schnabel,et al.  Epstein‐Barr virus load in whole blood is associated with immunosuppression, but not with post‐transplant lymphoproliferative disease in stable adult heart transplant patients , 2008, Transplant international : official journal of the European Society for Organ Transplantation.

[6]  Alan M. Miller,et al.  Prospective Study of Sequential Reduction in Immunosuppression, Interferon Alpha-2B, and Chemotherapy for Posttransplantation Lymphoproliferative Disorder , 2008, Transplantation.

[7]  M. Gulley,et al.  Laboratory assays for Epstein-Barr virus-related disease. , 2008, The Journal of molecular diagnostics : JMD.

[8]  K. Olthoff,et al.  EBV PCR in the Diagnosis and Monitoring of Posttransplant Lymphoproliferative Disorder: Results of a Two‐Arm Prospective Trial , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[9]  D. Rowe,et al.  Chronic High Epstein‐Barr Viral Load State and Risk for Late‐Onset Posttransplant Lymphoproliferative Disease/Lymphoma in Children , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[10]  S. Swerdlow.  Post-transplant lymphoproliferative disorders , 2008 .

[11]  P. Gaulard,et al.  Primary Cutaneous Peripheral T-Cell Lymphoma, Rare Subtype , 2008 .

[12]  R. Hetzer,et al.  Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[13]  C. Klein,et al.  CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  Lawrence R. Johnson,et al.  Gene Expression Profiling of Epstein-Barr Virus-positive and -negative Monomorphic B-cell Posttransplant Lymphoproliferative Disorders , 2007, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[15]  H. Volk,et al.  Evidence for Genetic Susceptibility Towards Development of Posttransplant Lymphoproliferative Disorder in Solid Organ Recipients , 2007, Transplantation.

[16]  R. Kotloff,et al.  Association between elevated whole blood Epstein-Barr virus (EBV)-encoded RNA EBV polymerase chain reaction and reduced incidence of acute lung allograft rejection. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[17]  R. Stuart,et al.  Posttransplantation lymphoproliferative disorder—The great mimic in liver transplantation: Appraisal of the clinicopathologic spectrum and the role of Epstein‐Barr virus , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[18]  S. Swerdlow.  T-cell and NK-cell posttransplantation lymphoproliferative disorders. , 2007, American journal of clinical pathology.

[19]  F. Wolfe,et al.  The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation. , 2007, Arthritis and rheumatism.

[20]  H. Riess,et al.  Quantitative analysis of EBV-specific CD4/CD8 T cell numbers, absolute CD4/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD. , 2007, Transplant immunology.

[21]  G. Bhagat,et al.  Cytogenetic analysis of B-cell posttransplant lymphoproliferations validates the World Health Organization classification and suggests inclusion of florid follicular hyperplasia as a precursor lesion. , 2007, Human pathology.

[22]  Y. Tomita,et al.  Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. , 2007, The Journal of rheumatology.

[23]  Mark Avigan,et al.  Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease. , 2007, Journal of pediatric gastroenterology and nutrition.

[24]  N. Frey,et al.  The management of posttransplant lymphoproliferative disorder , 2007, Medical oncology.

[25]  Lawrence R. Johnson,et al.  Impact of Epstein-Barr Virus in Monomorphic B-cell Posttransplant Lymphoproliferative Disorders: A Histogenetic Study , 2006, The American journal of surgical pathology.

[26]  J. Wagner,et al.  Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation. , 2006, Blood.

[27]  V. Aiello,et al.  Post-transplantation lymphoproliferative disorder in pediatric patient. , 2006, Arquivos brasileiros de cardiologia.

[28]  A. Monaco,et al.  Use of an immune function assay to monitor immunosuppression for treatment of post‐transplant lymphoproliferative disorder , 2006, Pediatric transplantation.

[29]  H. Heslop,et al.  Use of cytokine polymorphisms and Epstein–Barr virus viral load to predict development of post‐transplant lymphoproliferative disorder in paediatric liver transplant recipients , 2006, Clinical transplantation.

[30]  Sonali M. Smith,et al.  Post‐transplant lymphoproliferative disorder subtypes correlate with different recurring chromosomal abnormalities , 2006, Genes, chromosomes & cancer.

[31]  L. Agodoa,et al.  Posttransplant Lymphoproliferative Disorders after Renal Transplantation in the United States in Era of Modern Immunosuppression , 2005, Transplantation.

[32]  H. Heslop,et al.  Quantitative EBV Viral Loads and Immunosuppression Alterations can Decrease PTLD Incidence in Pediatric Liver Transplant Recipients , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[33]  C. Brensinger,et al.  Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine , 2005, Gut.

[34]  E. Macintyre,et al.  Characteristic Pattern of Chromosomal Imbalances in Posttransplantation Lymphoproliferative Disorders: Correlation with Histopathological Subcategories and EBV Status , 2005, Transplantation.

[35]  M. Franco,et al.  Epstein – Barr viral load, interleukin-6 and interleukin-10 levels in post-transplant lymphoproliferative disease: A nested case – control study in a renal transplant cohort , 2005, Leukemia & lymphoma.

[36]  W. Padberg,et al.  ATG induction therapy: long‐term effects on Th1 but not on Th2 responses , 2005, Transplant international : official journal of the European Society for Organ Transplantation.

[37]  R. Fennell,et al.  Hodgkin's lymphoma after post‐transplant lymphoproliferative disease in a renal transplant recipient , 2004, Pediatric transplantation.

[38]  B. Trost,et al.  Evaluation of histogenesis of B-lymphocytes in pediatric EBV-related post-transplant lymphoproliferative disorders , 2004, Bone Marrow Transplantation.

[39]  E. Jaffe,et al.  Post-transplant lymphoproliferative disease (PTLD): lymphokine production and PTLD , 2004, Springer Seminars in Immunopathology.

[40]  M. Nalesnik.  Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD) , 2004, Springer Seminars in Immunopathology.

[41]  M. Salizzoni,et al.  Epstein-Barr virus infection in 59 orthotopic liver transplant patients , 2004, Medical Microbiology and Immunology.

[42]  S. Webber,et al.  Posttransplantation lymphoproliferative disorders. , 2003, Pediatric clinics of North America.

[43]  D. Rossi,et al.  Molecular histogenesis of posttransplantation lymphoproliferative disorders. , 2003, Blood.

[44]  K. Karube,et al.  Differential Chemokine, Chemokine Receptor and Cytokine Expression in Epstein-Barr Virus-associated Lymphoproliferative Diseases , 2003, Leukemia & lymphoma.

[45]  X. Mariette,et al.  Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. , 2002, Blood.

[46]  J. Manning,et al.  Epstein–Barr Virus-Positive B-Cell Lymphoproliferative Disorders Arising in Immunodeficient Patients Previously Treated With Fludarabine for Low-Grade B-Cell Neoplasms , 2002, The American journal of surgical pathology.

[47]  T. Hongyo,et al.  Gene Mutations in Lymphoproliferative Disorders of T and NK/T Cell Phenotypes Developing in Renal Transplant Patients , 2002, Laboratory Investigation.

[48]  M. Steurer,et al.  Hepatosplenic γδ-T-cell lymphoma with leukemic course after renal transplantation * , 2002 .

[49]  C. Dunphy,et al.  Flow cytometric immunophenotyping in posttransplant lymphoproliferative disorders. , 2002, American journal of clinical pathology.

[50]  M. Gulley,et al.  Frequent expression of the tumor necrosis factor receptor-associated factor 1 in latent membrane protein 1-positive posttransplant lymphoproliferative disease and HIV-associated lymphomas. , 2001, Human pathology.

[51]  M. Green,et al.  Predicting outcome from post‐transplant lymphoproliferative disease: A risky business , 2001, Pediatric transplantation.

[52]  J. Tomaszewski,et al.  Post‐transplant lymphoproliferative disease in children , 2001, Pediatric transplantation.

[53]  S. Cockfield.  Identifying the patient at risk for post‐transplant lymphoproliferative disorder , 2001, Transplant infectious disease : an official journal of the Transplantation Society.

[54]  J. Tanner,et al.  The Epstein–Barr virus and post‐transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis , 2001, Transplant infectious disease : an official journal of the Transplantation Society.

[55]  J. Armitage,et al.  Clinical and pathological features of posttransplant lymphoproliferative disorders: influence on survival and response to treatment. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[56]  P. Brousset,et al.  Post renal transplantation human herpesvirus 8‐associated lymphoproliferative disorder and Kaposi's sarcoma , 2001, British journal of haematology.

[57]  P. Gaulard,et al.  Peripheral T/NK‐cell lymphoma: a report of the IXth Workshop of the European Assocation for Haematopathology , 2001, Histopathology.

[58]  R. Pelletier,et al.  A gene polymorphism associated with posttransplant lymphoproliferative disorder. , 2001, Transplantation proceedings.

[59]  R. Porcher,et al.  Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disorders. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[60]  M. DeBaun,et al.  Posttransplant Lymphoproliferative Disease in Children: Correlation of Histology to Clinical Behavior , 2001, Journal of pediatric hematology/oncology.

[61]  T. Gross.  Treatment of Epstein-Barr virus-associated posttransplant lymphoproliferative disorders. , 2001, Journal of pediatric hematology/oncology.

[62]  L. Wedderburn,et al.  Clonal Expansions in Acute EBV Infection Are Detectable in the CD8 and not the CD4 Subset and Persist with a Variable CD45 Phenotype1 , 2000, The Journal of Immunology.

[63]  S. Fan,et al.  Microsatellite Analysis in Post-Transplantation Lymphoproliferative Disorder to Determine Donor/Recipient Origin , 2000, Modern Pathology.

[64]  J. Wagner,et al.  Rapid reconstitution of Epstein-Barr virus-specific T lymphocytes following allogeneic stem cell transplantation. , 2000, Blood.

[65]  T. Starzl,et al.  The long-term efficacy of multivisceral transplantation. , 2000, Transplantation proceedings.

[66]  T. Starzl,et al.  Posttransplant lymphoproliferative disorders in small bowel allograft recipients. , 2000, Transplantation proceedings.

[67]  Y. Kwong,et al.  Post‐transplantation lymphoproliferative disease of natural killer cell lineage: a clinicopathological and molecular analysis , 2000, British journal of haematology.

[68]  A. Buda,et al.  Lymphoproliferative disorders in heart transplant recipients: role of hepatitis C virus (HCV) and Epstein‐Barr virus (EBV) infection , 2000, Transplant international : official journal of the European Society for Organ Transplantation.

[69]  B. Brando,et al.  Incidence and clinical characteristics of posttransplant lymphoproliferative disorders: report from a single center , 2000, Transplant international : official journal of the European Society for Organ Transplantation.

[70]  J. Tuttle-Newhall,et al.  The pathology of liver-localized post-transplant lymphoproliferative disease: a report of three cases and a review of the literature. , 2000, The American journal of surgical pathology.

[71]  F. Davi,et al.  Expression of p16/INK4a in posttransplantation lymphoproliferative disorders. , 2000, The American journal of pathology.

[72]  B. Julian,et al.  Postransplant lymphoproliferative disorder localized near the allograft in renal transplantation. , 2000, Transplantation.

[73]  G. Remuzzi,et al.  Epstein-Barr virus-negative lymphoproliferate disorders in long-term survivors after heart, kidney, and liver transplant. , 2000, Transplantation.

[74]  S. Swerdlow,et al.  Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity? , 2000, The American journal of surgical pathology.

[75]  S. Alkan,et al.  Mucosa-associated lymphoid tissue-type lymphomas occurring in post-transplantation patients. , 2000, The American journal of surgical pathology.

[76]  F. Baldanti,et al.  The immunosuppression and potential for EBV reactivation of fludarabine combined with cyclophosphamide and dexamethasone in patients with lymphoproliferative disorders , 1999, British journal of haematology.

[77]  E. Kieff,et al.  Epstein-barr virus-induced posttransplant lymphoproliferative disorders , 1999 .

[78]  D. Burstein,et al.  Posttransplantation plasmacytic proliferations related to Kaposi's sarcoma-associated herpesvirus. , 1999, The American journal of surgical pathology.

[79]  E. Jaffe,et al.  Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. , 1999, Blood.

[80]  R. Ambinder,et al.  The biology of Epstein–Barr virus in post‐transplant lymphoproliferative disease , 1999, Transplant infectious disease : an official journal of the Transplantation Society.

[81]  A. Norton,et al.  Monoclonal Epstein‐Barr virus‐related lymphoproliferative disorder following adult acute lymphoblastic leukaemia , 1999, British journal of haematology.

[82]  P. Gaulard,et al.  Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation , 1999, Hepatology.

[83]  N. Harris,et al.  Interleukin-18, interferon-gamma, IP-10, and Mig expression in Epstein-Barr virus-induced infectious mononucleosis and posttransplant lymphoproliferative disease. , 1999, The American journal of pathology.

[84]  P. Riikonen,et al.  Successful treatment of monoclonal, aggressive Epstein-Barr virus-associated B-cell lymphoproliferative disorder in a child with acute lymphoblastic leukemia. , 1999, Medical and pediatric oncology.

[85]  T. Barbui,et al.  Primary effusion lymphoma after heart transplantation: a new entity associated with human herpesvirus-8 , 1999, Leukemia.

[86]  D. Hébert,et al.  Lymphoproliferative disorders after organ transplantation in children. , 1999, Transplantation.

[87]  M. Nalesnik,et al.  Polymorphism and T-cell infiltration in posttransplant lymphoproliferative disorders. , 1999, Transplantation proceedings.

[88]  J Wagner,et al.  B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome , 1999, Bone Marrow Transplantation.

[89]  T. Starzl,et al.  Cytokine mRNA profiles in Epstein–Barr virus‐associated post‐transplant lymphoproliferative disorders , 1999, Clinical transplantation.

[90]  E. Cesarman,et al.  BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome. , 1998, Blood.

[91]  P. Kuo,et al.  Epstein-Barr virus-related posttransplantation lymphoproliferative disorder involving pancreas allografts: histological differential diagnosis from acute allograft rejection. , 1998, Human pathology.

[92]  J. Sixbey,et al.  Spontaneous loss of viral episomes accompanying Epstein-Barr virus reactivation in a Burkitt's lymphoma cell line. , 1998, The Journal of infectious diseases.

[93]  E. Cesarman,et al.  The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant , 1998, Cancer.

[94]  S. Alkan,et al.  Post-transplantation lymphoproliferative disorder of the NK-cell type: a case report and review of the literature. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[95]  J. Locker,et al.  Clonal and morphological variation in a posttransplant lymphoproliferative disorder: evolution from clonal T-cell to clonal B-cell predominance. , 1998, Human pathology.

[96]  X. Mariette,et al.  Lymphoproliferative disorders in rheumatoid arthritis patients on low-dose methotrexate. , 1998, Revue du rhumatisme.

[97]  J. Reyes,et al.  Epstein-Barr virus infections in children after transplantation of the small intestine. , 1998, The American journal of surgical pathology.

[98]  H. Koeppen,et al.  Morphologic bone marrow changes in patients with posttransplantation lymphoproliferative disorders. , 1998, The American journal of surgical pathology.

[99]  D. Crawford,et al.  Analysis of the T‐cell micro‐environment in Epstein–Barr virus‐related post‐transplantation B lymphoproliferative disease , 1998, The Journal of pathology.

[100]  F. Davi,et al.  Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity? , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[101]  K. Montone,et al.  Posttransplantation lymphoproliferative disorder: changing manifestations of disease in a renal transplant population. , 1997, Critical reviews in diagnostic imaging.

[102]  J. Byrd,et al.  Detection of Epstein-Barr virus in transformations of low-grade B-cell lymphomas after fludarabine treatment. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[103]  B. Angus,et al.  Alpha interferon gene deletions in post‐transplant lymphoma , 1997, British journal of haematology.

[104]  J. Cayuela,et al.  Epstein-Barr virus-associated lymphoproliferative disease during methotrexate therapy for psoriasis. , 1997, Archives of dermatology.

[105]  C. McLean,et al.  Key features distinguishing post-transplantation lymphoproliferative disorders and acute liver rejection. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[106]  S. Swerdlow,et al.  Cytologic features of post‐transplant lymphoproliferative disorder , 1997, Diagnostic cytopathology.

[107]  T. Starzl,et al.  Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients. , 1997, Transplantation.

[108]  O. Kamel.  Iatrogenic lymphoproliferative disorders in nontransplantation settings. , 1997, Seminars in diagnostic pathology.

[109]  N. Harris,et al.  Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop. , 1997, Seminars in diagnostic pathology.

[110]  S. Swerdlow.  Classification of the posttransplant lymphoproliferative disorders: from the past to the present. , 1997, Seminars in diagnostic pathology.

[111]  H. Heslop,et al.  Control of virus-induced lymphoproliferation: Epstein-Barr virus-induced lymphoproliferation and host immunity. , 1997, Molecular medicine today.

[112]  R. Larson,et al.  Microsatellite analysis of posttransplant lymphoproliferative disorders: determination of donor/recipient origin and identification of putative lymphomagenic mechanism. , 1996, Cancer research.

[113]  G. Trucco,et al.  Lymphoproliferative disorder involving the cervix in a patient being treated with FK-506. , 1996, Gynecologic oncology.

[114]  J. Lacy,et al.  Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[115]  A. Demetris,et al.  Renal allograft involvement by Epstein-Barr virus associated post-transplant lymphoproliferative disease. , 1996, The American journal of surgical pathology.

[116]  Nalesnik Ma.  Posttransplantation lymphoproliferative disorders (PTLD): current perspectives. , 1996, Seminars in thoracic and cardiovascular surgery.

[117]  S. Swerdlow,et al.  Recurrent Epstein-Barr virus-associated lesions in organ transplant recipients. , 1996, Human pathology.

[118]  P. Isaacson,et al.  Low grade gastric B‐cell lymphoma of mucosa associated lymphoid tissue in immunocompromised patients , 1996, Histopathology.

[119]  G. Delsol,et al.  Hodgkin's disease after transplantation. , 1996, Transplantation.

[120]  L. Swinnen,et al.  Characterization of postcardiac transplant lymphomas. Histology, immunophenotyping, immunohistochemistry, and gene rearrangement. , 1996, Archives of pathology & laboratory medicine.

[121]  C. Meijer,et al.  Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders. , 1995, The American journal of pathology.

[122]  E. Kremmer,et al.  Bc16/Laz3 rearrangements in post‐transplant lymphoproliferative disorders , 1995, British journal of haematology.

[123]  Yi Fang Liu,et al.  Molecular genetic analysis demonstrates that multiple posttransplantation lymphoproliferative disorders occurring in one anatomic site in a single patient represent distinct primary lymphoid neoplasms , 1995, Cancer.

[124]  S. Yousem,et al.  Discrimination of Epstein-Barr virus-related posttransplant lymphoproliferations from acute rejection in lung allograft recipients. , 1995, Archives of pathology & laboratory medicine.

[125]  E. Kremmer,et al.  The expression of Epstein-Barr virus latent proteins is related to the pathological features of post-transplant lymphoproliferative disorders. , 1995, The American journal of pathology.

[126]  D. Hanto,et al.  Classification of Epstein-Barr virus-associated posttransplant lymphoproliferative diseases: implications for understanding their pathogenesis and developing rational treatment strategies. , 1995, Annual review of medicine.

[127]  E. Cesarman,et al.  Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. , 1995, Blood.

[128]  R. L. Barker,et al.  Posttransplantation plasma cell dyscrasias , 1994, Cancer.

[129]  L. Young,et al.  EPstein‐barr virus in inflammatory diseases of the liver and liver allografts: An in situ hybridization study , 1994, Hepatology.

[130]  M. Nalesnik,et al.  Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders. , 1994, Transplantation science.

[131]  V. Leblond,et al.  Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation. , 1994, Transplantation.

[132]  D. Dunn,et al.  Clinical characteristics of post-transplant lymphoproliferative disorders. , 1994, The American journal of medicine.

[133]  M. Steinbuch,et al.  Immunoregulatory abnormalities in patients with Epstein-Barr virus-associated B cell lymphoproliferative disorders. , 1994, Transplantation.

[134]  F. Sigaux,et al.  Oligoclonal expansion of CD8+ CD57+ T cells with restricted T-cell receptor beta chain variability after bone marrow transplantation. , 1994, Blood.

[135]  J. Locker,et al.  Lymphoma resembling hodgkin disease after posttransplant lymphoproliferative disorder in a liver transplant recipient , 1993, Cancer.

[136]  R. Michler,et al.  Management of lymphoproliferative disorders after cardiac transplantation. , 1993, The Annals of thoracic surgery.

[137]  M. Gulley,et al.  Posttransplantation lymphoproliferative disorders. , 1993, American journal of clinical pathology.

[138]  A. Fischer,et al.  Therapy for transplant-related lymphoproliferative diseases. , 1993, Hematology/oncology clinics of North America.

[139]  T. Starzl,et al.  Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. , 1992, The New England journal of medicine.

[140]  S. Swerdlow,et al.  Post‐transplant lymphoproliferative disorders: a morphologic, phenotypic and genotypic spectrum of disease , 1992, Histopathology.

[141]  T. Starzl,et al.  Experience with posttransplant lymphoproliferative disorders in solid organ transplant recipients. , 1992, Clinical transplantation.

[142]  B. Griffith,et al.  Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. , 1991, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[143]  J. Cohen.  Epstein‐Barr Virus Lymphoproliferative Disease Associated with Acquired Immunodeficiency , 1991, Medicine.

[144]  D. Weisenburger,et al.  Epstein-Barr viral genome in lymph nodes from patients with Hodgkin's disease may not be specific to Reed-Sternberg cells. , 1991, The American journal of pathology.

[145]  J. Locker,et al.  Molecular genetic analysis of lymphoid tumors arising after organ transplantation. , 1989, The American journal of pathology.

[146]  N. Harris,et al.  Lymphoproliferative disorders and hematologic malignancies following organ transplantation. , 1989, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[147]  D. Canioni,et al.  Lymphadenopathy in Renal Transplant Patients Treated with Immunosuppressive Antibodies (OKT3 and Anti‐thymocyte Globulin): A Report of the Nine Cases , 1989, The American journal of surgical pathology.

[148]  T. Billiar,et al.  Inclusion of uncomplicated infectious mononucleosis in the spectrum of Epstein-Barr virus infections in transplant recipients. , 1988, Transplantation.

[149]  B. Burke,et al.  Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. , 1988, Blood.

[150]  T. Starzl,et al.  THE FREQUENCY OF EPSTEIN‐BARR VIRUS INFECTION AND ASSOCIATED LYMPHOPROLIFERATIVE SYNDROME AFTER TRANSPLANTATION AND ITS MANIFESTATIONS IN CHILDREN , 1988, Transplantation.

[151]  J. Locker,et al.  The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. , 1988, The American journal of pathology.

[152]  J. Rosai,et al.  Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. , 1981, Cancer research.